Ischemic heart disease - treatment through regenerative medicine

When ischemic heart disease (IHD) is treated and such its forms, particularly, as myocardial infarction and angina pectoris then treatment with fetal stem cell provides clearly positive result. Ischemic heart disease (IHD) is caused, as a rule, by atherosclerosis of coronary vessels. During this condition the plaques are formed on the walls of the arteries and make the passage thinner or block the vessels completely, obstructing the blood flow to cardiac muscle. At first the narrowing of the coronary vessels is not substantial. It is manifested in breast pang during physical exercise, stress, coldness or overeating. If plaque is destroyed clots appear that block the vessel and bring to development of myocardial infarction – death of part of heart muscle tissue caused by its «hunger». If IHD is left untreated, the shortage of oxygen brings to the malfunction of pumping, which the main function of the heart. This leads to insufficient delivery of blood to other organs. This condition is called chronic cardiac insufficiency.

Fetal stem cell for Ischemic heart disease 

As opposed to famous drug and surgery methods of IHD treatment when the goal is to preserve what was not destroyed by myocardial infarction, the fetal stem cell treatment provides new stable growth of healthy tissue in the cordial muscle (myocardium). As a result the treatment is more effective than the traditional one. Apart from ability of stem cells to differentiate to different types of cells, including cells of heart, they are also able to stimulate formation and growth of blood vessels (angiogenesis) and this plays the leading role in the development of additional vascular collaterals.

The patients who had myocardial infarction and suffer from angina pectoris receive the fetal stem treatment of ectodermal and mesenchymal origin. The appropriate therapy is appointed before treatment that provides the most endurable and stable effect alongside with injection of fetal stem cells. The quality of patient’s life is considerably enhanced. Our specialists conduct permanent monitoring of patient’s condition after treatment and the medication doses are adjusted.

2-3 months later after treatment with medication that includes fetal stem cells there is notable enhancement in the clinical treatment course of ischemic heart disease IHD. It was manifested in 2 times decrease of angina pectoris attacks if compared with the initial condition of the patient. The dose of antianginal medications was considerably reduced. All patients stress bigger physical activity and note the improvement of general state. The enhancement of overall health is objectively observed. The patients have higher tolerance to physical load, fewer symptoms of heart failure: shortness of breath, fatigue, weakness, swellings, hepatomegaly. The concentration of atherogenic lipids in the blood that take part in formation of atherosclerotic plaques is decreased. The blood cholesterol level and cholesterol content of low-density lipoprotein is reduced by 20-25%, while cholesterol content of high-density lipoproteins increases in general by 20%.

The duration of IHD treatment in clinic is 2 days, as a rule.